Neuraxis, INC (NRXS)
Data as of , from SEC Form 4 filings.
See up to 3 months of NRXS. The 7-day demo opens the 1M and 3M ranges and puts NRXS on your watchlist.
Start 7-day demoLatest NRXS insider trades
About Neuraxis, INC (NRXS)
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
- CARMEL, IN
- 24
- 2023
- XASE
NRXS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 2,533 | $12K |
| Grant or award | 16 | 2,328,971 | |
| Other acquisition / disposition | 6 | 1,926,880 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NRXS insider transactions (Form 4)
5036 Form 4 filings on record, the earliest from Jan 17, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Brian Allen Carrico - Officer | Open-market purchase | Common Stock | 268 | $4.84 | $1K | |
| Thomas Joeseph Carrico - Officer | Open-market purchase | Common Stock | 328 | $4.84 | $2K | |
| Timothy Robert Henrichs - Officer | Open-market purchase | Common Stock | 1,937 | $4.84 | $9K | |
| Thomas Joeseph Carrico - Officer | Grant or award | Common Stock | 193,678 footnote F1 | - footnote F1 | - | |
| Thomas Joeseph Carrico - Officer | Other | Stock Options | 306,236 | $6.94 | $2.13M | |
| Thomas Joeseph Carrico - Officer | Grant or award | RSU | 306,236 | - footnote F2 | - | |
| Thomas Joeseph Carrico - Officer | Other | RSU | 306,236 | - footnote F2 | - | |
| ||||||
| Adrian Miranda - Officer | Grant or award | Common Stock | 199,106 footnote F1 | - footnote F1 | - | |
| Adrian Miranda - Officer | Other | Stock Options | 337,204 | $6.94 | $2.34M | |
| Adrian Miranda - Officer | Grant or award | RSU | 337,204 | - footnote F2 | - | |
| Adrian Miranda - Officer | Other | RSU | 337,204 | - footnote F2 | - | |
| ||||||
| Brian Allen Carrico - Officer | Grant or award | Common Stock | 199,188 footnote F1 | - footnote F1 | - | |
| Brian Allen Carrico - Officer | Other | Stock Options | 320,000 | $6.94 | $2.22M | |
| Brian Allen Carrico - Officer | Grant or award | RSU | 320,000 | - footnote F2 | - | |
| Brian Allen Carrico - Officer | Other | RSU | 320,000 | - footnote F2 | - | |
| ||||||
| Bradley Mitchell Watkins - Director | Grant or award | Common Stock | 26,073 footnote F1 | $6.28 footnote F1 | $164K | |
| ||||||
| Adrian Miranda - Officer | Grant or award | RSU | 133,341 | $6.28 | $837K | |
| Jane Elizabeth Keyser - Director | Grant or award | Common Stock | 26,073 footnote F1 | $6.28 footnote F1 | $164K | |
| ||||||
| Timothy Robert Henrichs - Officer | Grant or award | RSU | 141,479 | $6.28 | $888K | |
 Kristin A. Ferge - Director | Grant or award | Common Stock | 31,134 footnote F1 | $6.28 footnote F1 | $196K | |
| ||||||
| Thomas Joeseph Carrico - Officer | Grant or award | RSU | 135,906 | $6.28 | $853K | |
| Brian Allen Carrico - Officer | Grant or award | RSU | 193,329 | $6.28 | $1.21M | |
| Gil Aharon - Director | Grant or award | Common Stock | 2,226 footnote F1 | - footnote F1 | - | |
| Gil Aharon - Director | Grant or award | Common Stock | 43,930 footnote F2 | $6.28 footnote F2 | $276K | |
| Gil Aharon - Director | Grant or award | Common Stock | 40,068 footnote F1 | - footnote F1 | - | |
| ||||||
| Gil Aharon - Director | Grant or award | Common Stock | 12,304 | - footnote F3 | - | |
| Gil Aharon - Director | Grant or award | Common Stock | 221,917 | - footnote F3 | - | |
| ||||||
| Timothy Robert Henrichs - Officer | Open-market purchase | Common Stock | 7,593 | $1.96 | $15K | |
| Thomas Joeseph Carrico - Officer | Open-market purchase | Common Stock | 667 | $1.96 | $1K | |
| Brian Allen Carrico - Officer | Open-market purchase | Common Stock | 8,060 | $1.96 | $16K | |
| Adrian Miranda - Officer | Grant or award | RSU | 47,569 | $4.63 | $220K | |
| Bradley Mitchell Watkins - Director | Grant or award | Common Stock | 21,598 | $4.63 footnote F1 | $100K | |
| ||||||
| Jane Elizabeth Keyser - Director | Grant or award | Common Stock | 21,598 | $4.63 footnote F1 | $100K | |
| ||||||
| Timothy Robert Henrichs - Officer | Grant or award | RSU | 75,231 | $4.63 | $348K | |
| Thomas Joeseph Carrico - Officer | Grant or award | RSU | 47,569 | $4.63 | $220K | |
| Brian Allen Carrico - Officer | Grant or award | RSU | 94,173 | $4.63 | $436K | |
| Brian Hannasch - 10% Owner | Open-market purchase | Common Stock | 40,000 | $4.65 footnote F1 | $186K | |
| Brian Hannasch - 10% Owner | Open-market purchase | Common Stock | 40,000 | $4.92 footnote F2 | $197K | |
| ||||||
| Gil Aharon - Director | Grant or award | Common Shares | 21,598 | $4.63 footnote F2 | $100K | |
| ||||||
| Kristin A. Ferge - Director | Grant or award | Common Stock | 21,598 | $4.63 footnote F1 | $100K | |
| ||||||
| Adrian Miranda - Officer | Grant or award | RSU | 10,000 | $2.18 | $22K | |
| Adrian Miranda - Officer | Grant or award | RSU | 30,000 | $2.18 | $65K | |
| Adrian Miranda - Officer | Grant or award | RSU | 35,000 | $2.42 | $85K | |
| Timothy Robert Henrichs - Officer | Grant or award | RSU | 8,037 | $2.43 | $20K | |
| Timothy Robert Henrichs - Officer | Grant or award | RSU | 100,000 | $2.43 | $243K | |
| Timothy Robert Henrichs - Officer | Grant or award | RSU | 66,000 | $2.18 | $144K | |
| Timothy Robert Henrichs - Officer | Grant or award | RSU | 67,980 | $2.42 | $165K | |
| Thomas Joeseph Carrico - Officer | Grant or award | RSU | 10,000 | $2.18 | $22K | |
| Thomas Joeseph Carrico - Officer | Grant or award | RSU | 27,435 | $2.18 | $60K | |
| Thomas Joeseph Carrico - Officer | Grant or award | RSU | 35,000 | $2.42 | $85K | |
Item 5.02, 8.01
Item 8.01
Item 5.07
Item 8.01, 9.01
NRXS insider trading FAQ
What is the latest insider trade for NRXS?
Neuraxis, INC (NRXS) had 14 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for NRXS runs to 36 Form 4 filings, the earliest from 2025-01-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NRXS stock?
3 insider purchases of NRXS were filed in the last 90 days, totaling $12K.
How many insiders are selling NRXS stock?
No insider sales of NRXS were filed in the last 90 days. 2 sales are on record for this company.
Where can I see NRXS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NRXS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brian Allen Carrico view on EDGAR
- - Thomas Joeseph Carrico view on EDGAR
- - Timothy Robert Henrichs view on EDGAR
- - Thomas Joeseph Carrico view on EDGAR
- - Adrian Miranda view on EDGAR
- - Brian Allen Carrico view on EDGAR
- - Bradley Mitchell Watkins view on EDGAR
- - Adrian Miranda view on EDGAR
- - Jane Elizabeth Keyser view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where NRXS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NRXS with a 7-day demo
- NRXS on your watchlist
- Every NRXS Form 4 filing on record
- Up to 3 months of NRXS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
